Case Reports in Cardiology

Case Reports in Cardiology / 2017 / Article

Case Report | Open Access

Volume 2017 |Article ID 3652413 | https://doi.org/10.1155/2017/3652413

Rezo Jorbenadze, Johannes Patzelt, Meinrad Gawaz, Peter Seizer, Harald F. Langer, "Sequential Venous Percutaneous Transluminal Angioplasty and Balloon Dilatation of the Interatrial Septum during Percutaneous Edge-to-Edge Mitral Valve Repair", Case Reports in Cardiology, vol. 2017, Article ID 3652413, 3 pages, 2017. https://doi.org/10.1155/2017/3652413

Sequential Venous Percutaneous Transluminal Angioplasty and Balloon Dilatation of the Interatrial Septum during Percutaneous Edge-to-Edge Mitral Valve Repair

Academic Editor: Ertuğurul Ercan
Received08 May 2017
Accepted09 Jul 2017
Published09 Aug 2017

Abstract

Percutaneous edge-to-edge mitral valve repair (PMVR) is widely used for selected, high-risk patients with severe mitral valve regurgitation (MR). This report describes a case of 81-year-old woman presenting with severe and highly symptomatic mitral valve regurgitation (MR) caused by a flail of the posterior mitral valve leaflet (PML). PMVR turned out to be challenging in this patient because of a stenosis and tortuosity of both iliac veins as well as sclerosis of the interatrial septum, precluding the vascular and left atrial access by standard methods, respectively. We managed to achieve atrial access by venous percutaneous transluminal angioplasty (PTA) and balloon dilatation of the interatrial septum. Subsequently, we could advance the MitraClip® system to the left atrium, and deployment of the clip in the central segment of the mitral valve leaflets (A2/P2) resulted in a significant reduction of MR.

1. Introduction

Percutaneous edge-to-edge mitral valve repair (PMVR) has proven to be beneficial for patients with severe mitral valve regurgitation (MR), who are not eligible for conventional mitral valve repair. PMVR, however, can turn out to be challenging. For instance, anatomical variations of vascular access and sclerosis of the interatrial septum in some patients may represent obstacles, which render the procedure more challenging.

2. Case Report

We report the case of an 81-year-old woman, who was admitted to our hospital with progressive dyspnea for further clinical evaluation. Transesophageal echocardiography (TEE) revealed severe MR with normal left ventricular systolic function. An eccentric jet was caused by a flail of the posterior leaflet (PML) in segment P2 (Figures 1(a) and 1(b)). Coronary angiography showed no significant coronary artery disease (CAD). Our interdisciplinary heart team recommended PMVR because of the high risk of open surgery in this patient.

After establishing vascular access through the right femoral vein, we were not able to advance the transseptal needle through the introduced Preface® transseptal access sheath (Biosense Webster, CA) across an obstruction at the curvature of the tortuous iliac veins. Instead, we had to use a thin transseptal guidewire (SafeSept®, Pressure Products, CA), which was advanced through the transseptal access sheath. This SafeSept wire has a very sharp tip and requires 77% less force to cross the interatrial septum. Using this approach, we then switched to a more rigid transseptal guiding sheath (LAMP, St. Jude Medical), and left atrial access could finally be achieved by dilatation of the interatrial septum with gradually increasing sizes of percutaneous transluminal coronary angioplasty (PTCA) balloons (up to 5 mm) over the SafeSept wire (Figure 1(c); Supplemental Movie 1 in Supplementary Material available online at https://doi.org/10.1155/2017/3652413). Subsequently, we experienced another obstacle, as the dilator of the MitraClip steerable sheath system (Abbott Vascular) could not be advanced to the inferior vena cava over the placed ultrastiff wire (Amplatz, Cook Medical, Bloomington, IN), even when using a second superstiff buddy wire (Amplatz, Boston Scientific Corporation, San Jose, CA) (Figures 1(d), 1(e), and 1(f); Supplemental Movie 2). Furthermore, the left iliac vein had a similar obstruction precluding advancement of the MitraClip system. Thus, we carried out successive balloon dilatations of the right common iliac vein with gradually increasing balloon sizes up to 10 mm (Figure 1(g); Supplemental Movie 3). Deployment of the clip (Figures 1(h) and 1(i)) in the central segment of the mitral leaflets (A2/P2) resulted in a significant MR reduction (Figure 1(j)). We could discharge the patient from the hospital with a significantly improved 6-minute walk test few days after PMVR.

3. Discussion

PMVR presents a novel and innovative method for interventional mitral valve repair for patients with MR, who are not eligible for conventional heart surgery [1]. Less invasiveness and no need for extracorporeal circulation represent major advantages of PMVR over open heart surgery [2]. In some patients, however, anatomical circumstances may render PMVR difficult and in some cases even impossible. Besides difficult vascular access, existence of an atrial septal defect (ASD), a sclerotic interatrial septum, or a relatively small left atrium with additional presence of a prominent coumadin ridge, which can make stirring towards the mitral valve plane difficult, can complicate and prolong the procedure. If a significant ASD is present, the position of the MitraClip steering guide may not be stable enough. Crossing the iliac veins with the MitraClip guide catheter can represent a challenge during PMVR. Recently, a case of venous strangulation during PMVR was presented, which was overcome by implantation of a stent [3]. In our case, we were able to manage this vascular obstruction by percutaneous transluminal angioplasty (PTA) using PTA balloons of gradually increasing sizes. Multiple studies have shown that anticoagulation is needed after iliac venous stenting and sometimes even additional antiplatelet treatment is necessary for prevention of recurrent deep venous thrombosis [4]. In contrast, our approach has the advantage where no prolonged antithrombotic therapy is required. In addition to anatomical variation of the iliofemoral veins, thickening or lipomatous hypertrophy of the interatrial septum can represent a challenge for achieving the left atrial access. There are different methods for transseptal puncture, for example, by using radiofrequency or excimer laser catheters. Radiofrequency or laser energy can be helpful for transseptal puncture of a scarred, calcified, or patched atrial septum [5]. However, in our case we achieved the left atrial access via a SafeSept transseptal guidewire, a LAMP rigid transseptal guiding sheath, and gradual dilatation of the interatrial septum with PTCA balloons. We performed the transseptal puncture and the whole PMVR procedure under the guidance of TEE and fluoroscopy. However, intracardiac echocardiography (ICE) can also be used for monitoring of the intervention [6].

In conclusion, balloon angioplasty may be necessary for successful positioning of the MitraClip system and should be kept in mind as an option for establishing both vascular and left atrial access during PMVR.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Supplementary Materials

Supplemental Movie 1. Because of the sclerotic interatrial septum, we had to use a SafeSept® wire to cross the septum. Subsequently, balloon dilatation of the interatrial septum over the transseptal guidewire were carried out to be able to gain sufficient access to the left atrium.

Supplemental Movie 2. Because of a mechanical obstruction in the tortuous right common iliac vein advancing the MitraClip® steering guide or a commonly used dilator was not possible over the ultrastiff wire (Amplatz, Cook Medical, Bloomington, IN), even when using a second superstiff buddy wire.

Supplemental Movie 3. PTA using balloons with increasing diameter of up to 10 mm was carried out to overcome the mechanical obstruction of the iliac vein.

  1. Supplementary Material

References

  1. T. Feldman, E. Foster, D. G. Glower et al., “Percutaneous repair or surgery for mitral regurgitation,” The New England Journal of Medicine, vol. 364, no. 15, pp. 1395–1406, 2011. View at: Publisher Site | Google Scholar
  2. R. Beigel, N. C. Wunderlich, S. Kar, and R. J. Siegel, “The evolution of percutaneous mitral valve repair therapy: lessons learned and implications for patient selection,” Journal of the American College of Cardiology, vol. 64, no. 24, pp. 2688–2700, 2014. View at: Publisher Site | Google Scholar
  3. M. A. Al-Hijji, M. F. Eleid, H. Bjarnason, T. A. Foley, G. S. Reeder, and C. S. Rihal, “Venous strangulation as an unusual cause of mitraclip system delivery failure,” JACC Cardiovascular Interventions, vol. 8, no. 11, article 2113, pp. e189–e192, 2015. View at: Publisher Site | Google Scholar
  4. P. Eijgenraam, H. ten Cate, and A. J. ten Cate-Hoek, “Venous stenting after deep venous thrombosis and antithrombotic therapy: a systematic review,” Reviews in Vascular Medicine, vol. 2, no. 3, pp. 88–97, 2014. View at: Publisher Site | Google Scholar
  5. V. C. Babaliaros, J. T. Green, S. Lerakis, M. Lloyd, and P. C. Block, “Emerging applications for transseptal left heart catheterization: old techniques for new procedures,” Journal of the American College of Cardiology, vol. 51, no. 22, pp. 2116–2122, 2008. View at: Publisher Site | Google Scholar
  6. A. Henning, I. I. Mueller, K. Mueller et al., “Percutaneous edge-to-edge mitral valve repair escorted by left atrial intracardiac echocardiography (ICE),” Circulation, vol. 130, no. 20, pp. e173–e174, 2014. View at: Publisher Site | Google Scholar

Copyright © 2017 Rezo Jorbenadze et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views750
Downloads382
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.